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Summary
Increases in p53 protein levels after DNA damage
have largely been attributed to an increase in the half-
life of p53 protein. Here we demonstrate that in-
creased translation of p53 mRNA is also a critical step
in the induction of p53 protein in irradiated cells. Ri-
bosomal protein L26 (RPL26) and nucleolin were
found to bind to the 5 untranslated region (UTR) of
p53 mRNA and to control p53 translation and induc-
tion after DNA damage. RPL26 preferentially binds to
the 5UTR after DNA damage, and its overexpression
enhances association of p53 mRNA with heavier poly-
somes, increases the rate of p53 translation, induces
G1 cell-cycle arrest, and augments irradiation-induced
apoptosis. Opposite effects were seen when RPL26
expression was inhibited. In contrast, nucleolin over-
expression suppresses p53 translation and induction
after DNA damage, whereas nucleolin downregulation
promotes p53 expression. These findings demon-
strate the importance of increased translation of p53
in DNA-damage responses and suggest critical roles
for RPL26 and nucleolin in affecting p53 induction.
Introduction
The p53 gene is commonly mutated in human cancers
(Hainaut et al., 1998), and inherited mutations in the
gene lead to the profoundly cancer-predisposing Li-
Fraumeni syndrome (Malkin et al., 1990). The p53 pro-
tein plays a critical role in cellular responses to DNA
damage and other stresses by inhibiting proliferation or
inducing programmed cell death (Kastan et al., 1991;
Vogelstein et al., 2000; Vousden and Lu, 2002; Giaccia
and Kastan, 1998). The reason that inherited or spo-
radic mutations in the p53 gene contribute to the devel-
opment of malignancies is presumably related to these
cellular-stress-response functions. Failure to induce
appropriate growth arrest or apoptosis after DNA dam-
age is thought to promote genetic instability or inappro-
priate survival of damaged cells. Thus, an inability to
activate p53 function after DNA damage or other cellu-
lar stresses can contribute to the generation of viable,
genetically altered cells that can lead to malignancy.
Optimal induction of growth arrest or apoptosis after
DNA damage requires an increase in the intracellular
levels of functional p53 protein (Giaccia and Kastan,
1998). The increases in p53 protein levels are depen-
dent on the ATM protein kinase after ionizing irradiation
(IR) (Kastan et al., 1992) and on the ATR protein kinase*Correspondence: michael.kastan@stjude.orgafter UV irradiation and many other types of cellular
stress (Tibbetts et al., 1999; Hammond et al., 2002).
There is a measurable increase in the half-life of p53
protein after DNA damage (Maltzman and Czyzyk, 1984;
Price and Calderwood, 1993), and the increases in cellu-
lar p53 protein levels have largely been attributed to
this change in half-life. p53 protein is normally a very
short-lived cellular protein with rapid proteasomal deg-
radation in unperturbed cells. The HDM2 protein
(MDM2 in mice) directly binds to p53 protein (Momand
et al., 1992) and functions as an E3 ubiquitin ligase to
facilitate the degradation of p53 (Honda et al., 1997;
Haupt et al., 1997; Kubbutat et al., 1997). Posttransla-
tional modifications of HDM2 after DNA damage ap-
pear to inhibit the ability of HDM2 to bind to p53 (Khos-
ravi et al., 1999; Maya et al., 2001; Shieh et al., 1997),
thus decreasing the proteasomal degradation of p53
protein and increasing cellular levels of the protein.
Similarly, induction of the ARF tumor suppressor by on-
cogenes and other cellular signals leads to increases in
p53 protein levels by ARF protein binding to HDM2 and
inhibiting HDM2-mediated degradation of p53 (Sherr
and Weber, 2000). Thus, cells with overexpressed
HDM2 or inactive ARF are similar to cells containing
mutated p53 genes in that normal p53 regulation is
lacking.
Several reports have suggested that translational
regulation may also contribute to p53 induction after
DNA damage. In the initial reports of p53 induction after
ionizing irradiation, the protein-synthesis inhibitor
cycloheximide was shown to block p53 induction, and
marked increases in labeling of p53 protein with
[35S]methionine were noted early after treatment (Kas-
tan et al., 1991, 1992). Subsequently, a translation sup-
pressor element was reported in the 3#UTR of the p53
mRNA (Fu and Benchimol, 1997; Fu et al., 1999), and a
stem-loop structure was predicted in the 5#UTR of the
murine p53 gene (Mosner et al., 1995). Interestingly, p53
was suggested to negatively regulate its own transla-
tion by direct binding of p53 protein to this 5#UTR stem-
loop structure (Mosner et al., 1995). Two other proteins
have also been reported to modulate p53 translation:
thymidylate synthase suppresses p53 translation by
binding to the coding sequence of p53 mRNA (Chu et
al., 1999; Ju et al., 1999), and HuR (Hu antigen R) en-
hances the translation efficiency of p53 after ultraviolet
irradiation by binding to an AU-rich sequence at the
3#UTR of p53 mRNA (Mazan-Mamczarz et al., 2003).
Despite suggestions that translational control of p53
might be important, the extent, importance, and mech-
anism of p53 translational regulation after DNA damage
has remained unclear. We have now investigated the
importance of p53 translational regulation and the mech-
anisms involved. Significant increases in p53 translation
were demonstrated after ionizing irradiation, and an im-
portant role for the 5#UTR in regulating translation of
human p53 was observed in vitro and in cells. Unbiased
screens for proteins that specifically bind to the 5#UTR
of p53 mRNA identified ribosomal protein L26 (RPL26)
and nucleolin, and both were found to bind to p53
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onstrated that they modulate p53 protein levels and af-
fect p53 induction after DNA damage. Overexpression
of RPL26 enhances p53 translation and p53 protein
levels, and short interfering RNA (siRNA) inhibition of
RPL26 blocks p53 induction after DNA damage. These
modulations of p53 responses by RPL26 have the ex-
pected consequences on growth arrest and apoptosis.
The converse effects were found with manipulation of
nucleolin expression, and nucleolin cooperates with
oncogenic Ras in transforming primary rat fibroblasts.
These studies reveal a critical role for translational reg-
ulation of p53 protein after DNA damage and demon-
strate that two novel regulators can compete with each
other to regulate p53 synthesis through binding to the
5#UTR of p53 mRNA.
Results
Effects of DNA Damage and the 5UTR
on p53 Translation
As previously demonstrated in ML-1 cells (Kastan et
al., 1991), brief exposure of MCF7 cells to the protein-
synthesis inhibitor cycloheximide reduces induction of
p53 protein after IR (Figure 1A). Since increases in total
p53 protein levels are usually detectable in cells within
an hour after IR, in order to convincingly demonstrate
increases in p53 translation after IR, it is best examined
under conditions where total p53 protein levels are not
changing. This was accomplished by labeling newly
synthesized p53 protein by very brief labeling pulses
with [35S]methionine at very early time points after IR
or under conditions where additional effects of protein
turnover were avoided by pretreating the cells with a
proteasome inhibitor. Though total levels of p53 protein
were indistinguishable in unirradiated versus irradiated
cells in both of these experimental settings, a signifi-
cant increase in metabolically labeled, newly synthe-
sized p53 was apparent in the irradiated cells, thus
demonstrating increased translation after DNA damage
(Figure 1B and data not shown).
To begin to explore whether the 5#UTR of p53 mRNA
affects its translation in cells, the amount of p53 protein
generated by mRNA containing various lengths of the
5#UTR was examined. The National Center of Biotech-
nology Information (NCBI) database (http://www.ncbi.
nlm.nih.gov/) lists several p53 mRNA molecules that
contain various lengths of the 5#UTR, the longest being
251 nucleotides (accession number NM_000546). A
previous study suggested that the majority of cellular
p53 mRNA has a 5#UTR of 140–145 nucleotides, with a
minor population containing 176 nucleotides (Tuck and
Crawford, 1989). RNA ligase-mediated rapid amplifica-
tion of 5# cDNA ends (RLM-5#RACE) was employed to
evaluate the predominant p53 mRNA species in several
human cell lines. The major species contained a 5#UTR
of 139–143 nucleotides (62%), and a minor population
contained 161–190 nucleotides (see Figure S1A in the
Supplemental Data available with this article online).
Similar to the prediction for the mouse p53 mRNA
5#UTR, the mfold program (Zuker, 2003) predicted that
this human 5#UTR would contain a highly ordered sec-
ondary structure that could suppress translation (free
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cigure 1. Translational Control of p53 Protein Levels
A) Cycloheximide blocks the induction of p53 after irradiation. p53
nd actin protein levels in MCF7 cells treated with and without 10
M cycloheximide (CHX) 10 min before 5 Gy irradiation (IR) were
ssessed by immunoblot. Cells were unirradiated (−) or harvested
0 or 20 min after IR.
B) Translation of p53 is increased by irradiation. p53 protein was
mmunoprecipitated from MCF7 cells that had been labeled for 5
in with [35S]methionine 30 min after exposure to 0 or 10 Gy IR
nd was assessed by autoradiography. Cells had been pretreated
ith 50 M MG132 and immunoblotting (WB) showed equivalent
mounts of p53 in the immunoprecipitate (middle panel). Analysis
f whole-cell extracts (WCE) showed equal amounts of [35S]methi-
nine incorporated into the irradiated and unirradiated cells (bot-
om panel).
C) The 5#UTR p53 mRNA affects the level of p53 protein. H1299
ells were transfected with p53 mRNA having 5#UTRs of various
engths, a full-length coding sequence, a complete 3#UTR, and
oly(A). Firefly luciferase mRNA was an internal control. The
mounts of p53, firefly luciferase, and actin present 24 hr after
ransfection were assessed by immunoblot.nergy of folding G = −66 kcal/mol for the 191 nt
#UTR and −60 kcal/mol for the 145 nt; Figure S1B). To
valuate a potential impact of the 5#UTR on p53 protein
xpression, several p53 mRNAs were generated with
arious lengths of the 5#UTR attached to the full-length
oding sequence with a full-length 3#UTR and poly(A)
RPL26 Regulates p53 mRNA Translation
51sequence. Transfection of these RNA species into p53
null H1299 cells demonstrated that the length of the
5#UTR had a significant impact on the amount of p53
protein that was generated. Maximal p53 expression
occurred when the 5#UTR contained 75 nucleotides,
while p53 was much less efficiently translated when the
mRNA had a relatively long (192 nucleotides or 251 nu-
cleotides) or very short 5#UTR (1 nucleotide) (Figure 1C).
Identification of RPL26 and Nucleolin as p53 5UTR
Binding Proteins
Since the 5#UTR of p53 mRNA appeared to affect p53
protein levels, and given that UTR binding proteins are
involved in the translational regulation of gene expres-
sion (Gray and Wickens, 1998; Stripecke et al., 1994),
we utilized two screens to search for proteins that bind
to the 5#UTR of p53 mRNA. A yeast three-hybrid screen
(Figure S2) (SenGupta et al., 1996) identified several
clones that bind nonspecifically to the 5#UTR of p53
mRNA and four clones that appeared to exhibit some
specificity relative to binding to the 3#UTR of p53
mRNA (Figure 2A and Table S1). The four clones that
showed some specificity for binding (ribosomal protein
[RP] S3a, RPS13, RPL26, and nucleostemin), as well as
the nonspecific clone RPL5, which had previously been
reported to stabilize p53 protein (Dai and Lu, 2004),
were subcloned into enhanced green fluorescence pro-
tein (EGFP) tagged mammalian expression vectors and
tested for their ability to modulate p53 expression
levels. While RPL5 weakly increased p53 expression,
only RPL26 overexpression significantly increased p53
protein levels (Figure 2B). Thus, subsequent experi-
ments focused on exploring the importance of RPL26
in controlling p53 protein expression.
To verify the binding of RPL26 to the 5#UTR of p53
mRNA, in vitro and cell-based binding assays were uti-
lized. Incubation of recombinant His-tagged RPL26
protein with the 32P-labeled p53 5#UTR RNA signifi-
cantly slowed the electrophoretic mobility of the RNA,
and the complex was supershifted by addition of anti-
penta His antibody (Figure 2C). An RNA pull-down as-
say was employed using lysates from unirradiated or
irradiated MCF7 cells, and the binding of selected pro-
teins to biotinylated p53 5#UTR versus p53 3#UTR was
evaluated. RPL26 was preferentially precipitated by the
5#UTR after irradiation, but no RPL26 was detected
when the 3#UTR was used as bait (Figure 2D). The abil-
ity of endogenous RPL26 protein to bind to p53 mRNA
in viable cells was evaluated by examining immuno-
precipitates using an anti-RPL26 antibody for the pres-
ence of p53 mRNA. A rabbit polyclonal antibody was
generated against human RPL26 (Figures S3A–S3C),
and the p53 mRNA was detected by RT-PCR in an
RPL26 immunoprecipitate from MCF7 cells, with more
p53 mRNA precipitated in the lysates from irradiated
cells (Figure 2E).
An RNA pull-down assay was also utilized as a
screen for proteins that specifically bind to the 5#UTR
of p53 mRNA. Using biotinylated p53 5#UTR and 3#UTR
RNAs as bait and mass spectrometry to identify un-
known binding proteins, several protein bands were
identified as preferentially binding to the 5#UTR (Figure
2F and Table S2), including nucleolin. Most of the pro-teins identified in this screen were known to interact
with nucleolin as part of large ribonucleocomplexes
(Yanagida et al., 2001). The specific interaction of
nucleolin with the 5#UTR of p53 mRNA was also ob-
served in an RNA pull-down assay with a Western blot
readout (Figure 2D). However, in contrast to RPL26,
there was no detectable change in the binding of
nucleolin after IR (Figure 2D). As previously suggested
(Mosner et al., 1995), p53 protein was also identified as
a p53 5#UTR binding protein (Figure 2D). The interac-
tion between nucleolin and p53 mRNA in living cells
was confirmed by identifying p53 mRNA in anti-nucleo-
lin immunoprecipitates by RT-PCR using a p53 5#UTR
primer (Figure 2G). It is noted that these assays do not
distinguish whether it is nucleolin or some other protein
in the ribonucleocomplex that directly interacts with the
p53 mRNA, but subsequent studies (see below) dem-
onstrated that manipulation of nucleolin levels mark-
edly affects p53 protein translation, thus suggesting
functional importance for this particular member of
the complex.
RPL26 Overexpression Increases p53 Levels,
Function, and Translation
To explore the functional role of RPL26 in controlling
p53 protein levels, it was overexpressed in the human
lines MCF7, U2OS, RKO, and HCT116 and the mouse
line BaF3. In all cases, transfected RPL26 significantly
increased levels of p53 protein (data not shown). The
transfected GFP-RPL26 showed an intracellular distri-
bution similar to endogenous RPL26, being found in
nucleoli, diffusely distributed in the nucleoplasm, and
in cytoplasm (Figures S3C and S4A). As expected,
much of cytoplasmic RPL26 was bound to ribosomes
(Figure S4B). A dose-dependent relationship between
levels of RPL26 transfected into MCF7 cells and levels
of endogenous p53 protein was observed (Figure 3A).
RPL26 also enhanced the amount of p53 protein in-
duced by IR. Overexpression of RPL26 had no effect
on the expression of several other proteins (actin and
ATM, Figure 3A; nucleolin, topoisomerase I, eIF4E, and
hnRNPU, data not shown). Kinetic analysis showed that
expression of the p53 target genes p21 and HDM2 was
induced as expected by irradiation and was augmented
by RPL26 overexpression (Figure 3B). Because optimal
induction of p53 after IR requires activation of the ATM
kinase, it was important to rule out an effect of RPL26
overexpression on ATM activation. Activation of the
ATM kinase, as measured by autophosphorylation of
Ser1981 (Bakkenist and Kastan, 2003), was not affected
by RPL26 overexpression in either unirradiated or irra-
diated cells (Figure 3A). Further supporting the concept
that RPL26 overexpression was affecting p53 directly
rather than through ATM was the observation that
RPL26 overexpression did not induce phosphorylation
of p53 at Ser15 in unirradiated cells despite the pres-
ence of abundant p53 protein (Figure 3B). These results
suggest that overexpression of RPL26 induces func-
tional p53 accumulation without activation of the DNA-
damage checkpoint pathway. A luciferase reporter as-
say was employed to confirm that augmentation of p53
expression by RPL26 correlates with increased basal
and IR-induced activity of genes containing either a
Cell
52Figure 2. Identification of p53 5#UTR-Specific Binding Proteins
5 × 105 clones were screened to yield 128 primary HIS3-positive clones; 97 were positive for LacZ, 33 were selected by 5-FOA sensitivity,
and 10 contained open reading frames.
(A) Binding of proteins expressed by each pACT2 clone to the p53 5#UTR and 3#UTR. Additional information on the binding proteins is
described in Table S1.
(B) Candidate clones were transfected into MCF7 cells, and their effects on p53 and actin expression were compared by immunoblotting 24
hr after transfection.
(C) RNA-EMSA. 32P-labeled 5#UTR was incubated with His-control protein (−,−) or His-RPL26 (−,+); supershift was assessed by addition of
anti-penta His antibody (+,+).
(D) RNA pull-down assay. Whole-cell extracts (WCE) prepared from MCF7 cells 1 hr after 0 (−) or 10 (+) Gy IR were mixed with biotinylated
p53 5#UTR or 3#UTR. Input and bound fractions were analyzed by immunoblotting.
RPL26 Regulates p53 mRNA Translation
53ures S6A and S6B). To demonstrate that the siRNA was
(E) RPL26 binds to p53 5#UTR in cells. Control IgG or anti-RPL26 (N-terminal and C-terminal mixture) was used to immunoprecipitate lysates
from MCF7 cells 30 min after 0 or 10 Gy IR, and bound RNA was amplified by PCR of the 5#UTR of p53. PCR products were visualized by
ethidium bromide staining. SM: size marker.
(F) Identification of p53 5#UTR binding proteins by RNA pull-down. Cytoplasmic extracts from MCF7 cells 1 hr after 0 or 10 Gy IR were
incubated with biotinylated 3# or 5#UTR of p53 and precipitated with streptavidin beads. Gel was stained by cypro ruby. Several proteins
identified by mass spectrometric analysis are shown by labels. SM: size marker. Information on binding proteins is also shown in Table S2.
(G) IP-RT-PCR for p53 5#UTR as described in (E), using anti-nucleolin antibody or control mouse IgG.
transfected with p53 mRNA without its 5#UTR (5#UTRp53 consensus target sequence (PG13) or the p21CIP1
promoter (Figure 3C).
The increases in p53 protein levels associated with
RPL26 overexpression could result from pretransla-
tional, translational, or posttranslational effects. RPL26
transfection did not change the cellular levels of p53
mRNA (Figure S5A), thus suggesting that any changes
in p53 protein levels were posttranscriptional. Similarly,
RPL26 transfection did not alter the half-life of p53 pro-
tein (Figure S5B), thus ruling out increased protein half-
life as an explanation for the increased p53 protein
levels. Indeed, assessment of p53 translation by [35S]
methionine pulse-labeling demonstrated that RPL26
transfection directly increases p53 translation in a
dose-dependent manner and augments the irradiation-
induced increase in p53 translation (Figure 3D). The
same experiment was performed in the p53 mutant cell
line SW480 to further eliminate any possible contribu-
tion of an increase in p53 half-life or total levels to the
increased p53 metabolic labeling after IR. Transfection
of RPL26 into SW480 cells increased p53 translation,
particularly after IR (Figure 3E). Importantly, RPL26
overexpression did not alter overall cellular translation
levels, as shown by similar amounts of newly synthe-
sized (i.e., [35S]methionine-labeled) protein in whole-
cell extracts (Figures 3D–3F, bottom panel). Similarly,
specific evaluation of the translation levels of other
short-lived proteins, such as c-Myc and ERK3 (Rabbitts
et al., 1985; Coulombe et al., 2003), demonstrated that
their translation was not altered by upregulation of
RPL26 (Figure 3F).
Actively translated mRNAs are preferentially associ-
ated with polysomes, so the distribution of p53 mRNA
on ribosomes was assessed by sucrose-gradient cen-
trifugation. Overexpression of RPL26 induced a mea-
surable redistribution of p53 mRNA into heavier poly-
somes (Figure 3G), whereas the distribution of actin
mRNA was unaffected. Therefore, RPL26 binds to the
5#UTR of p53 mRNA, changes the distribution of p53
mRNA in polysomes, and measurably increases p53
translation.
Decreasing Endogenous RPL26 Levels Attenuates
p53 Expression and Translation
To explore whether modulation of endogenous RPL26
affects p53 protein levels, cellular RPL26 was downreg-
ulated by introduction of siRNA. Transfection of MCF7
cells with RPL26 siRNA reduced endogenous RPL26 by
over 75% and markedly attenuated p53 induction by IR
(Figure 4A). This had no measurable effects on ATM
levels or activation. Similarly, reduction of endogenous
RPL26 significantly limited increases in p53 translation
and protein levels after ultraviolet (UV) irradiation (Fig-modulating p53 by specifically affecting RPL26 and not
some other intracellular target, an RPL26 cDNA was
generated that is resistant to the effects of the siRNA.
The C-terminal domain of RPL26 was noted to have
stimulatory effects on p53 translation (see below), and
this domain was used to complement the inhibition of
RPL26 by a siRNA that targeted the N-terminal half of
the RPL26 RNA. This siRNA-resistant construct re-
versed the inhibition of p53 induction by IR caused by
the siRNA (Figure 4B). Similarly, the siRNA blunted IR-
induced increases in p53 translation, and the siRNA-
resistant RPL26 construct reversed this inhibition (Fig-
ure 4C).
The knockdown of RPL26 protein levels in cells did
not alter overall translation as assessed by the total
amounts of [35S]methionine incorporated in total cellu-
lar proteins (Figure 4C). Furthermore, the translation of
other short-lived proteins, c-Myc and ERK3, was not
altered by downregulation of RPL26 (Figure 4D). To fur-
ther exclude the possibility that overexpression or
knockdown of RPL26 could be affecting overall transla-
tion rather than having relatively specific effects on p53
translation, we examined the effects of these manipula-
tions on ribosome homeostasis. The total amount of
ribosomal RNA obtained from GFP-RPL26-overex-
pressing cells or RPL26 knockdown cells was indistin-
guishable (Figure S7A and data not shown). In addition,
processing of ribosomal mRNA was unaffected by
either manipulation up to 48 hr after transfection (Fig-
ures S7B and S7C). These experiments suggest that
transient overexpression of GFP-RPL26 or knockdown
of RPL26 does not perturb ribosome biogenesis or ho-
meostasis in the time frame of these experiments.
Further evidence for an important role for endoge-
nous RPL26 in p53 translation came from examination
of the association of p53 mRNA with polysomes in unir-
radiated versus irradiated cells. As previously reported
(Fu and Benchimol, 1997), we observed a relative redis-
tribution of p53 mRNA to the heavier polysome frac-
tions in irradiated cells (Figure 4E). Downregulation of
endogenous RPL26 levels by siRNA blunted this radia-
tion-induced redistribution (Figure 4E).
RPL26 Effects Depend on the 5UTR of p53 mRNA
and Require a Minimal Region of RPL26
We mapped the domain of the p53 5#UTR to which
RPL26 binds by transfecting constructs that had vari-
ous lengths of p53 5#UTR into p53 null H1299 cells in
the presence or absence of RPL26 and examined the
levels of p53 expression. RPL26 cotransfection was
able to increase the levels of p53 expression when the
p53 5#UTR included at least nucleotides −1 to –22 (Fig-
ure 5A). No increase in p53 expression was seen in cells
Cell
54Figure 3. RPL26 Overexpression Increases p53 Protein Translation, Levels, and Function
(A) Levels of various proteins assessed by immunoblot 1 hr after 0 or 5 Gy IR in MCF7 cells transfected with increasing amounts of GFP-
RPL26.
(B) Levels of various proteins assessed by immunoblot at various times after 0 (−) or 5 Gy IR in MCF7 cells transfected with a GFP-mock or
a GFP-RPL26 vector.
(C) Reporter assay of p53 transcriptional activity using a generic p53 consensus target sequence or a p21 promoter sequence in cells
cotransfected with a GFP-mock or a GFP-RPL26 vector. Firefly luciferase activity was evaluated 3 hr after exposure of cells to 0 (−) or 5 Gy
IR relative to an internal Renilla luciferase control. Error bars show SEM.
(D) RPL26 stimulates p53 expression by increasing translation. Pulse-labeled p53 was immunoprecipitated from MCF7 cells transfected with
increasing amounts of GFP-RPL26 30 min after 0 or 5 Gy IR and assessed by autoradiography (second panel) and immunoblot (third panel).
Total amount of GFP-RPL26 was assessed by immunoblot (top panel), and total [35S]methionine incorporation into cellular proteins was
assessed by autoradiography (bottom panel).
(E) As in (D), but using SW480 cells.
(F) GFP-RPL26 overexpression specifically increases translation of p53 mRNA. [35S]methionine pulse-labeled p53, ERK3, and c-Myc were
immunoprecipitated from MCF7 cells transfected with GFP-mock or GFP-RPL26 and assessed by autoradiography and immunoblot.
(G) RPL26 alters the polysome distribution of p53 mRNA. RNA from MCF7 cells transfected with a GFP-mock or GFP-RPL26 vector was
fractionated by sucrose-gradient centrifugation and analyzed by Northern blot (1, lightest fraction; 9, heaviest fraction). Fractionated ribo-
somal RNA was also resolved by agarose gel electrophoresis and visualized with ethidium bromide (bottom panel).
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55Figure 4. Reduction of RPL26 Levels Reduces p53 Protein Translation and Induction
(A) Immunoblot of various proteins in MCF7 cells transfected with a control siRNA or siRNA against RPL26 after 0 (−) or 5 Gy IR.
(B) An siRNA-resistant RPL26 vector re-establishes p53 induction in siRNA-treated cells. Top panel shows the schema of the siRNA and
mutant RPL26 vector. MCF7 cells were transfected with a control siRNA or siRNA against RPL26 and then transfected with a GFP-mock
vector (mock) or the GFP-RPL26 deletion mutant plasmid (RPL26mt) 24 hr after siRNA transfection. Twenty-four hours after plasmid transfec-
tion, cells were irradiated and were harvested 3 hr later, and protein levels were assessed by immunoblot.
(C) p53 translation is complemented by the siRNA-resistant mutant RPL26 vector. A GFP-mock vector (mock) or the GFP-RPL26 deletion
mutant plasmid (RPL26mt) was transfected into MCF7 cells previously transfected with RPL26 siRNA as described in (B). Cells were exposed
to 0 or 5 Gy IR and pulse-labeled (5 min) with [35S]methionine, and newly synthesized p53 was assessed by autoradiography. Total levels of
immunoprecipitated p53 and [35S]methionine incorporation into total cellular proteins are shown.
(D) GFP-RPL26 knockdown specifically decreases translation of p53 mRNA. [35S]methionine pulse-labeled p53, ERK3, and c-Myc were
immunoprecipitated from MCF7 cells transfected with control siRNA or RPL26 siRNA and assessed by autoradiography and immunoblot.
(E) RPL26 siRNA reduces translocation of p53 mRNA to heavier polysomes after IR. MCF7 cells transfected with a control siRNA (upper three
panels) or siRNA against RPL26 (lower three panels) were exposed to 0 or 5 Gy IR, and RNA extracted 30 min later was fractionated by
sucrose-gradient centrifugation. Fractions were analyzed as described in Figure 3.
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56Figure 5. Mapping RPL26 and p53 5#UTR In-
teraction Domains
(A) Capped p53 mRNA containing variable
5#UTR sequences was cotransfected with
firefly luciferase mRNA and either a GFP-
RPL26 expression vector or a GFP-mock ex-
pression vector into H1299 cells, and protein
levels were assessed by immunoblot. Equiv-
alence of transfection efficiency, mRNA
content, and expression is indicated by the
similarity of the firefly luciferase levels.
(B) Effects of RPL26 on p53 translation were
assessed in rabbit reticulocyte lysates con-
taining p53 cDNAs with variable 5#UTR se-
quences, firefly luciferase cDNA, and either
His-RPL26 or His-control cDNA. Expression
was assessed by immunoblot.
(C) Various RPL26 deletion mutants were
transfected into MCF7 cells, and endoge-
nous p53 levels were assessed by immu-
noblot.
(D) Schematic summary of localization,
5#UTR binding, and p53 induction of RPL26
deletion mutants. Nclo., nucleoli; Ncl., nu-
cleoplasm; Cyt., cytoplasm.
(E) Binding of wild-type and mutant con-
structs of RPL26 to the p53 5#UTR, as-
sessed by IP-RT-PCR using anti-GFP anti-
body. PCR products were visualized by
ethidium bromide staining.nt length 1). Firefly luciferase mRNA containing an unre-
lated, vector-derived 5#UTR of 71 nucleotides was cot-
ransfected as an internal control, and no effects of
RPL26 were seen on firefly luciferase protein levels.
Similar results were obtained examining the impact of
RPL26 on translation of p53 mRNA using a rabbit retic-
ulocyte in vitro transcription/translation system (Figure
5B). Thus, both cell-based systems (Figures 1C and 5A)
and in vitro systems (Figure 5B) demonstrate that the
p53 5#UTR affects p53 translation/expression levels
and that the effect of RPL26 on p53 translation requires
the presence of the 5#UTR. As noted in the RNA trans-
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cection assays (Figure 1C), these translation assays
Figures 5A and 5B) also demonstrated a negative ef-
ect of the longer 5#UTR sequences, suggesting nega-
ive regulatory elements in these sequences.
RPL26 contains 145 amino acids with a KOW motif
Kyrpides et al., 1996) in its middle region and a resolv-
se motif at its carboxyl terminus. A series of deletion
utants of RPL26 were constructed to determine
hich part of RPL26 is required to induce p53 expres-
ion. Mutants lacking either the carboxy-terminal (d1)
r the amino-terminal (d5) domains of RPL26 were still
apable of increasing p53 protein levels with a minimal
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57overlapping region containing amino acids 63–90 (in-
cluding the KOW motif) (Figure 5D). These results sug-
gest that a central domain of RPL26 protein is particu-
larly important in this regulatory effect on p53. These
deletion mutants were further characterized for their in-
tracellular localization, their ability to bind to the p53
5#UTR, and their ability to induce p53 protein (Figures
5C–5E). There was an excellent correlation between the
ability of the mutants to bind to the 5#UTR and their
ability to increase p53 protein levels in cells. The one
exception to this, the mutant d2, bound to the 5#UTR
but still did not induce p53. This observation may impli-
cate the central domain containing the KOW motif in
the translation effect. Most importantly, we found no
examples of a fragment that induced p53 but failed to
bind to the 5#UTR.
RPL26 Affects p53-Dependent Apoptosis
and Cell-Cycle Arrest
The impact of RPL26 levels on p53 translation and in-
duction prompted us to investigate its impact on cellu-
lar functions that depend on p53. Murine BaF3 cells
undergo apoptosis in a p53-dependent manner at early
time points after IR when IL-3 is withdrawn (Canman et
al., 1995). Transfection of RPL26 increased the number
of BaF3 cells undergoing IR-induced apoptosis, and in-
hibition of p53 function by cotransfection with vectors
expressing either human papilloma virus (HPV) E6 or a
dominant-negative mutant p53 protein eliminated this
effect (Figure 6A). Conversely, downregulation of RPL26
with siRNA diminished irradiation-induced apoptosis
(Figure 6B). Transfection of RPL26 also increased 5-flu-
orouracil-dependent cell death in human HCT116 colon
cancer cells carrying wild-type p53 (Bunz et al., 1999)
but had no measurable effect in isogenic HCT116 cells
lacking p53 (Figure 6C). Again, transfection of RPL26
siRNA reduced the 5-fluorouracil-induced, p53-depen-
dent apoptosis (Figure 6D).
In many cell types and physiologic settings, p53 in-
duction results in G1 cell-cycle arrest rather than apo-
ptosis (Kastan et al., 1991; Canman et al., 1995). RPL26
was transfected into MCF7 cells alone or along with
HPV-E6 or dominant-negative p53 expression vectors,
and the cell-cycle distribution was examined 24 hr after
transfection. Overexpression of RPL26 induced a
marked G1 arrest that was abrogated when either HPV-
E6 or dominant-negative p53 was cotransfected (Figure
6E). The p53-dependent effects of RPL26 on cell prolif-
eration were also examined in a colony-growth assay.
Immortalized arf−/−p53+/+ or arf−/−p53−/− mouse embry-
onic fibroblasts were infected with retroviruses encod-
ing GFP alone or GFP-RPL26. Though infection with
RPL26 markedly suppressed cell growth in the arf−/−
p53+/+ cells, it had no measurable effect in the arf−/−
p53−/− cells, thus demonstrating that the growth arrest
was dependent on p53 but not ARF (Figure 6F).
Nucleolin Also Affects p53 Levels and Translation
The nucleolar protein, nucleolin, was also identified in
our screens as a protein that specifically interacted
with the p53 5#UTR (Figure 2F), and it has previously
been suggested that RPL26 is a component of the
nucleolin-containing ribonucleocomplex (Yanagida etal., 2001). We confirmed an interaction between RPL26
and nucleolin in coimmunoprecipitation assays (Figures
S8A and S8B). We did not observe any effect of irradia-
tion on the interaction, though such an effect might not
be expected with overexpressed transfected proteins.
The effects of modulating nucleolin on p53 protein
levels and translation were then explored. Transient
transfection of nucleolin into MCF7 cells reduced p53
protein levels in a dose-dependent manner (data not
shown) but had no effect on p53 mRNA levels (Figure
S9). Stable transfection of nucleolin into MCF7 cells
blunted IR induction of p53 protein (Figure 7A) and in-
hibited the IR-induced increase in p53 translation with-
out measurably affecting overall translation levels (Fig-
ure 7B). Endogenous nucleolin levels were reduced
w50% by infection of MCF7 cells with a short hairpin
RNA (shRNA) construct for nucleolin. This moderate re-
duction in nucleolin increased basal and IR-induced
p53 protein levels (Figure 7C) and p53 translation (Fig-
ure 7D). If nucleolin overexpression suppresses p53
function, then it might be expected to function as an
oncogene in a rat embryo fibroblast (REF) transforma-
tion assay. Early-passage REFs were infected with ret-
roviruses expressing GFP alone, GFP-nucleolin, or mu-
tant p53 (R175H) along with oncogenic mutant Ras.
Control infected REFs retained a flat morphology, while
cells infected with GFP-nucleolin or mutant p53 lost
contact inhibition and showed dramatic morphologic
changes (Figure 7E). Furthermore, both mutant p53 and
nucleolin infection resulted in proliferation and colony
formation in soft agar (Figure 7E).
Since both RPL26 and nucleolin bind to the 5#UTR of
p53 but induce opposing effects on p53 translation, it
was reasonable to inquire whether the two proteins
compete for these effects. Enforced expression of
nucleolin in MCF7 cells had the expected effect of re-
ducing basal and IR-induced p53 protein levels (Figure
7F). Cotransfecting RPL26 into these nucleolin-overex-
pressing cells reversed the blockade of p53 induction
in a dose-dependent manner (Figure 7F). Similarly,
transfection of RPL26 reversed the nucleolin-mediated
inhibition of p53 translation after IR (Figure 7G).
Discussion
The results here demonstrate that translational control
mechanisms are critically important in modulating cel-
lular levels of the p53 tumor-suppressor protein after
DNA damage. Measurable increases in the translation
of p53 mRNA after DNA damage were documented for
both wild-type and mutant p53 proteins, although in-
creased translation rates do not result in detectably in-
creased levels of mutant p53 protein because of its al-
ready long half-life. We identified three proteins, RPL26,
nucleolin, and p53 protein itself, that bind to the 5#UTR
of p53 both in vitro and in cells. Increased levels of
RPL26 enhance both basal and DNA-damage-induced
translation of p53 mRNA in vitro and in cells and en-
hance cellular functions dependent on p53, such as
cell-cycle arrest and apoptosis. The effects of RPL26
on p53 translation require the presence of the 5#UTR.
Reduction of RPL26 levels by siRNA blunt these p53-
dependent responses, thus demonstrating a role for en-
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58Figure 6. Cellular Consequences of RPL26 Overexpression or Knockdown
(A) Apoptosis of BaF3 cells induced by 5 Gy IR was measured in GFP-mock- or GFP-RPL26-overexpressing cells, which were cotransfected
with mock empty vector, E6, or dominant-negative p53. The percentage of apoptotic cells was determined by annexin V staining 3 hr after
IR. Cells were grown in the presence (open bars) or absence (filled bars) of IL-3. Error bars show SEM.
(B) Apoptosis of BaF3 cells induced by 5 Gy IR was measured in control-siRNA-transfected and RPL26-siRNA-transfected cells, and the
percentage of apoptotic cells was determined as above.
(C) Induction of apoptosis of HCT116 parental or HCT116 p53 null cells at various times by 300 M 5-fluorouracil treatment was measured
by annexin V staining.
(D) An experiment similar to (C) was performed in control-siRNA- or RPL26-siRNA-transfected cells.
(E) MCF7 cells overexpressing GFP-mock or GFP-RPL26 were cotransfected with mock, E6, or dominant-negative p53, and cell-cycle distribu-
tion was determined by BrdU pulse-label 24 hr after transfection. The G1/S ratio ± SEM obtained from three independent experiments is
shown. Open bars, mock transfectants; filled bars, RPL26 transfectants.
(F) Colony-survival assay of GFP-mock- and GFP-RPL26-transfected arf−/−p53+/+ mouse embryonic fibroblasts (MEFs) and arf−/−p53−/− MEFs;
crystal-violet-stained cells are shown.
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59Figure 7. Modulation of p53 by Nucleolin Manipulation
(A) Levels of p53 and p53 targets were assessed by immunoblot at various times after 5 Gy IR in MCF7 cells stably transfected with a GFP-
mock vector and a GFP-nucleolin vector.
(B) Levels of [35S]methionine-labeled p53 in the same MCF7 cells 30 min after 0 (−) or 5 (+) Gy IR.
(C) shRNA against nucleolin enhances p53 expression. MCF7 cells transfected with a control shRNA or shRNA against nucleolin (NCL)
exposed to 0 or 5 Gy were harvested 1 hr after IR and analyzed by immunoblot.
(D) As in (C), levels of [35S]methionine-labeled p53 in the same MCF7 cells 30 min after 0 or 5 Gy IR.
(E) Nucleolin overexpression induces REF transformation. Upper panel shows the morphological change of REFs transformed with oncogenic
Ras and GFP-mock, mutant p53 (R175H), or GFP-nucleolin; lower panel shows colony-formation activity in soft agar plate.
(F) Competition between RPL26 and nucleolin in modulating p53 protein levels. Levels of various proteins were assessed by immunoblot in
MCF7 cells that had been transiently transfected with nucleolin (NCL) and varying amounts of GFP-RPL26. Extracts were made 30 min after
exposure to 0 or 5 Gy IR.
(G) The effects of nucleolin and varying amounts of RPL26 on p53 translation in MCF7 cells were assessed as described above.
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60dogenous RPL26 in DNA-damage responses. Nucleolin
has the opposite effects on p53, with overexpression
reducing basal and DNA-damage-induced translation
and inhibition of nucleolin enhancing translation.
Though significant new insights have been gained
into the importance of translation in regulating p53 ac-
tivity and function and the roles of its 5#UTR and the
proteins RPL26 and nucleolin in this regulation, many
mechanistic details remain to be elucidated. The se-
quence of the p53 5#UTR predicts a highly structured
stem loop that would be expected to inhibit translation.
In fact, both the in vitro and cell-based translation
studies here suggest a sequence that inhibits transla-
tion in the general region where this structure should
be present and where RPL26 binds to the 5#UTR and
exerts its positive effects. Nucleolin promotes anneal-
ing of both RNA and DNA single-strand sequences
(Thyagarajan et al., 1998; Hanakahi et al., 2000), so its
inhibitory effects on p53 translation may reflect its abil-
ity to promote the double-strand RNA stem-loop struc-
tures in the 5#UTR. If this is the case, it is conceivable
that the stimulatory effects of RPL26 on p53 translation
result from RPL26 displacing nucleolin from the 5#UTR.
Yet because we detected no measurable differences in
the amount of nucleolin associated with the 5#UTR af-
ter IR or after transfection with RPL26, it may be more
likely that RPL26 facilitates a bypass of the stem-loop-
dependent inhibition of translation or even contributes
to unwinding of the stem loop.
Since p53 translation is increased after DNA damage
and both RPL26 and nucleolin contribute to the control
of p53 translation during this stress response, DNA
damage must somehow be signaling to one or both of
these proteins. Nucleolin binding to the p53 5#UTR
does not detectably change after IR, suggesting the
possibility that RPL26, but not nucleolin, is the modu-
lated target after DNA damage. Supporting this possi-
bility, we found that IR induced a measurable change in
the intracellular distribution of RPL26, but not nucleolin,
with a relative increase in the amount of RPL26 protein
located in the nucleoplasm (Figures S10A and S10B).
We have no evidence that this relative increase in nu-
cleoplasmic RPL26 after IR is related to its effects on
p53 translation. Perhaps this redistribution somehow
contributes to the increased movement of p53 mRNA
to polysomes. DNA damage can disrupt nucleolar in-
tegrity and has been reported to cause a release of
nucleolin from the nucleolus (Rubbi and Milner, 2003;
Daniely et al., 2002). Though immunofluorescence as-
says demonstrated a release of some nucleolin from
the nucleolus to the nucleus after UV irradiation (data
not shown), no significant release of either nucleolin or
RPL26 from nucleoli was noted after IR (Figure S10C).
Another potential effect of DNA damage on RPL26
could be the introduction of posttranslational modifica-
tions. In preliminary studies, we have demonstrated
that RPL26 is a phosphoprotein (data not shown), but
we have not yet identified any specific altered sites of
phosphorylation in the protein associated with DNA
damage. The other change that occurs in the cells after
IR is the increased levels of p53 protein itself; since p53
protein also appears to be binding to the 5#UTR of p53
mRNA, it is conceivable that its induction and binding
a
a
e
i
l
t
p
p
R
m
t
o
a
i
i
b
m
b
C
c
i
a
q
w
p
s
c
m
h
c
o
b
f
t
c
b
h
z
t
a
H
(
r
a
t
o
c
f
p
a
t
2
n
c
f
t
s
t
a
n
slso affect the relative interactions of nucleolin, RPL26,
nd the 5#UTR.
Based on observations presented here and in the lit-
rature to date, it is thus reasonable to suggest a model
n which nucleolin binds to the p53 5#UTR and stabi-
izes its stem-loop structure, thereby inhibiting p53
ranslation and maintaining low p53 protein levels in un-
erturbed cells. After cellular stress, binding of RPL26
rotein to the p53 5#UTR increases. The interaction of
PL26 with p53 mRNA alters the distribution of the
RNA on polysomes and could enhance p53 transla-
ion. Whether RPL26 overcomes the nucleolin inhibition
f translation simply because of its ability to alter the
ssociation of p53 mRNA with polysomes or whether
t has some other effect on the stem loop or on the
nteractions of nucleolin with the p53 5#UTR are possi-
ilities to be explored.
These mechanisms controlling protein translation
ay not be limited to p53 regulation but may rather
e of general significance in cellular stress responses.
ellular stresses such as hypoxia and high doses of
ertain types of DNA damaging agents are potent inhib-
tors of general protein translation in cells (Koumenis et
l., 2002; Deng et al., 2002). In order to maintain ade-
uate levels of selected proteins that help the cell cope
ith the stress, certain mechanisms must come into
lay to maintain the translation of these proteins de-
pite the general decrease in protein translation. p53 is
ertainly one example of a protein whose synthesis
ust be maintained, even in the face of stresses like
ypoxia (Koumenis et al., 2001, 2002). Though we spe-
ifically identified RPL26 and nucleolin as modulators
f p53 translation in these studies, it has previously
een reported that nucleolin binds to at least 40 dif-
erent mRNAs in response to genotoxic stress and that
his binding is an important component of the general
ellular response to stress (Yang et al., 2002). The RNA
inding protein, HuR, binds to the p53 3#UTR and en-
ances translation efficiency after UV irradiation (Ma-
an-Mamczarz et al., 2003), and several ribosomal pro-
eins have been reported to bind to HDM2 protein and
ffect p53 protein levels by inhibiting the association of
DM2 with p53 and increasing the p53 protein half-life
Dai et al., 2004; Dai and Lu, 2004; Jin et al., 2004; Loh-
um et al., 2003; Zhang et al., 2003). Thus, both positive
nd negative translational control of many different pro-
eins may be part of the highly coordinated response
f cells to DNA damage and other cellular stresses.
Though the p53 gene is mutated in many human can-
ers, there are many other human cancers where p53
unction is altered either because of expression of viral
roteins that inhibit p53 function or because of alter-
tions in other cellular proteins, such as HDM2 or ARF,
hat interact with p53 (Vogelstein et al., 2000; Sherr,
001). The properties described here for RPL26 and
ucleolin raise the possibility that their dysregulation
ould contribute to tumorigenesis by alteration of p53
unction. Since RPL26 is required for p53 induction af-
er DNA damage, it could function as a tumor-suppres-
or gene. One study identified mutations in RPL26 in
wo murine tumor cell lines resulting in a unique tumor-
ssociated antigen and a more aggressive tumor phe-
otype (Beck-Engeser et al., 2001). Human RPL26 re-
ides at chromosomal locus 17p13, near the commonly
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61deleted p53 gene and a chromosomal region commonly
altered in human tumors. Nucleolin functioned as an
oncogene that cooperates with mutant Ras in trans-
forming rat embryo fibroblasts. However, though
nucleolin levels tend to be higher in proliferating cells
than in stationary cells (Derenzini et al., 1995; Roussel
and Hernandez-Verdun, 1994) and one publication sug-
gested that it could cooperate with v-src in cellular
transformation (Gillet et al., 1993), there are no reported
systematic studies of nucleolin protein levels in tumor
cells implicating it in human tumorigenesis. One prelim-
inary report suggested that neuroblastoma with unfa-
vorable histology expresses higher levels of nucleolin
mRNA than do tumors with favorable histology (Ohira
et al., 2003). This would be a particularly interesting
possibility since neuroblastomas tend to retain wild-
type p53 gene sequences. The mechanistic insights
generated in this study suggest that possible roles for
RPL26 and nucleolin in human tumorigenesis should
be explored.
Experimental Procedures
Cell Manipulations
Standard approaches were used in cell culture, REF transforma-
tion, and purchase or generation of commercial and constructed
plasmids; details are given in Supplemental Data. Transient trans-
fections utilized Effectene (Qiagen, Valencia, California) or Lipofec-
tamine 2000 (Invitrogen). BaF3 cells were electroporated by using
the T20 program of the Nucleofector device and Nucleofector Kit
V (Amaxa Biosystems, Gaithersburg, Maryland). EGFP-mock and
EGFP-nucleolin stably overexpressed MCF7 cells were obtained by
selection in 2 mg/ml G418 (Invitrogen). Retrovirus production and
infection were performed as previously reported using 293T cells
(Sugimoto et al., 2003). For luciferase reporter assays, MCF7 cells
were transiently transfected with the pG13 and p21 firefly luciferase
reporter vector with pRL-SV40 Renilla luciferase internal control
vector. Firefly and Renilla luciferase activities were measured by
using the Dual-Luciferase reporter assay system (Promega) and a
MicroLumat Plus 96V luminometer (Berthold Technologies, Bad
Wildbad, Germany). siRNA specific for human RPL26 (CCGAAAG
GAUGAUGAAGUUUU) and mixtures of functional siRNA specific
for human and mouse RPL26 made by SMART pool technology
were obtained from Dharmacon (Lafayette, Colorado). A control
siRNA was obtained from Ambion (Austin, Texas). Cells were trans-
fected with a final concentration of 20 nM siRNA by using siPORT
transfection agent (Ambion). Sequences of short hairpin RNAs spe-
cific for nucleolin and control were 5#-AGAGCGAGATGCGAG
AACA-3# and 5#-AATCAGACGTGGACCAGAAGA-3#, respectively.
Cell-cycle distribution was analyzed by the bromodeoxyuridine
(BrdU) pulse-labeled method using the APC BrdU flow kit (BD Bio-
sciences, San Jose, California). To assess apoptosis, cells were
stained with APC-conjugated annexin V and 7-AAD (BD Biosci-
ences) 3 hr after irradiation.
5RACE and Identification of RNA Binding Proteins
RLM-5#RACE was performed using the Gene Racer kit (Invitrogen).
The amplified PCR products were TA cloned into pCR II TOPO (Invi-
trogen), and 100 independent clones were sequenced. pIIIA/MS2-
2-p53 5#UTR was used as a bait plasmid (Figure S2) in the yeast
three-hybrid system (SenGupta et al., 1996). Details are given in
Supplemental Data. Binding of unknown proteins to the p53 5#UTR
and 3#UTR was also analyzed by using cytoplasmic extracts of
MCF7 cells in RNA pull-down assays with biotinylated RNA targets
and analyzing binding proteins by mass spectrometry. Details are
given in Supplemental Data.
Immunoblots, Metabolic Labeling, and Immunoprecipitation
Polyclonal rabbit anti-RPL26 antibody was obtained by immunizing
rabbits with KLH-conjugated RPL26 peptides (amino [N] terminal,SKNRKRHFNAPSHIRRKI, or carboxy [C] terminal, RQVGKEKGYK
EETIEK), and antibody was purified by affinity chromatography on
an N-hydroxysuccinimide (NHS)-activated Sepharose 4 Fast Flow
column (Amersham Biosciences). For Western blotting, N-terminal
antibody was employed; for IF, C-terminal antibody was employed;
and for IP, N+C-terminal antibody was employed. Immunoblot pro-
cedures and commercial antibody details are given in Supplemen-
tal Data. For metabolic labeling, MCF7 cells were preincubated in
DMEM without methionine and cysteine with 5% dialyzed FCS for
1 hr. When indicated, preincubated cells were treated with proteo-
some inhibitor, 50 M MG132 (EMD Biosciences), for 1 hr; irradi-
ated with 5 Gy; and, 30 min after irradiation, labeled with 100 Ci/
ml of [35S]methionine (Amersham) for 5 min. Immunoprecipitation
procedures were standard and are detailed in Supplemental Data.
mRNA Transcription, Transfection, RNA EMSA, and IP-RT-PCR
In vitro transcription of capped p53 mRNA was performed using
the mMESSAGE mMACHINE kit (Ambion), and a poly(A) sequence
was added by using the poly(A) tailing kit (Ambion) using a T7 pro-
moter-sequenced-tagged p53 PCR product as template. Synthe-
sized mRNA was transfected into H1299 cells by using DMRIE-C
transfection reagent (Invitrogen). In vitro transcription and transla-
tion was achieved by using the TNT Quick Coupled transcription/
translation system (Promega). For RNA-EMSA, p53 5#UTR RNA
(−191 to 2) was generated by in vitro transcription with T7 polymer-
ase (Ambion) and 5# labeled with [32P]γ-ATP (Amersham) by using
T4 polynucleotide kinase (Promega). Radiolabeled RNA (150,000
cpm) was incubated with His-tagged RPL26 or a His-tagged con-
trol protein that was in vitro transcribed and translated in rabbit
reticulocyte lysate (Promega) in binding buffer (10 mM HEPES-KOH
[pH 7.5], 90 mM potassium acetate, 1.5 mM magnesium acetate,
2.5 mM DTT, and 40 U ribonuclease inhibitor [SUPERase·In, Am-
bion]) for 30 min at 30°C. RNA-protein complexes were resolved on
a 4.5% acrylamide (60:1 acrylamide to bisacrylamide), 5% glycerol,
and 0.5× Tris-borate-EDTA (TBE) gel and detected by autoradiogra-
phy. IP-RT-PCR was performed as previously described (Tenen-
baum et al., 2002).
Ribosome Analyses
mRNA distribution in polysomes was analyzed by a method modi-
fied from that described by Whitfield et al. (2000). Just before har-
vesting, the cells were treated with cycloheximide (0.1 mM) to fix
the mRNA on the polysomes and then washed in PBS and lysed
by gentle shaking in 0.5% NP40, 0.1 M NaCl, 10 mM MgCl2, 2 mM
DTT, 50 mM Tris-HCl (pH 7.5) containing 200 U/ml SUPERase·In,
100 g/ml cycloheximide, 200 g/ml heparin, protease inhibitor
cocktail (Roche Diagnostics), and 0.1mM PMSF. Nuclei and mem-
branes were removed from each lysate by centrifugation at 10,000 ×
g for 15 min, and each supernatant was layered on a 15% to 40%
(wt/vol) sucrose gradient (9 ml) in 0.15 M NaCl, 5 mM MgCl2, 25
mM Tris-HCl (pH 7.5) and centrifuged for 140 min at 35,000 rpm in
an SW41 rotor (Beckman Coulter, Fullerton, California). Fractions
were collected using a model 2110 fraction collector (Bio-Rad), and
RNA from each fraction was extracted using phenol/choroloform
followed by ethanol precipitation. RNA from each fraction was
treated with formamide, resolved by agarose gel electrophoresis,
transferred to nitrocellulose membrane, and analyzed for p53 and
actin mRNA by Northern blotting. Ribosomal RNA processing as-
says were performed as previously described (Sugimoto et al., 2003).
Supplemental Data
Supplemental Data include Supplemental Experimental Pro-
cedures, two tables, and ten figures and can be found with this
article online at http://www.cell.com/cgi/content/full/123/1/49/DC1/.
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